XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Revenues    
Product revenue, net $ 13,520,246 $ 1,439,826
Operating expenses    
Cost of sales 3,819,156 375,720
Research and development 182,865 78,020
Selling, general and administrative 11,490,370 5,146,443
Amortization of intangible assets 1,584,581 575,117
Total operating expenses 17,076,972 6,175,300
Loss from operations (3,556,726) (4,735,474)
Other (expense) income    
Other (expense), net (751,541) (195,386)
Gain from change in fair value of contingent consideration 2,336 0
Gain from warrant derivative liability 0 1,830
Total other (expense) income (749,205) (193,556)
Net loss $ (4,305,931) $ (4,929,030)
Weighted average number of common shares outstanding 121,585,939 15,325,921
Basic and diluted net loss per common share $ (0.04) $ (0.32)